Public Awareness
Tackling the NASH epidemic, introducing the NASH-CORE study
Tackling the NASH epidemic, introducing the NASH-CORE study
The global prevalence of non-alcoholic fatty liver disease (NAFLD) is 25%. It is considered to be endemic in Europe and a major potential threat to public health. Yet it appears to receive very limited attention. EASL International Liver Foundation aims to place the spotlight on NALFD and take the first... View Article
Learn more
Viral Hepatitis Elimination
Supporting Viral Hepatitis elimination in Mongolia
Supporting Viral Hepatitis elimination in Mongolia
Mongolia has the world’s highest rate of liver cancer mortality; nearly eight times the global average. The prevalence of chronic viral hepatitis B, C, and D is at endemic level, and constitutes the main reason cause of Mongolia’s world-leading liver cancer mortality rate. To tackle this deadly crisis, the Onom... View Article
Learn more
Viral Hepatitis Elimination
Elimination of Viral Hepatitis in Chronic Kidney Disease patients: a call to action
Elimination of Viral Hepatitis in Chronic Kidney Disease patients: a call to action
We are honoured to announce that we have joined forces with the European Renal Association- European Dialysis and Transplant Association (ERA-EDTA) to bring together expert Hepatologists and Nephrologists to eliminate viral hepatitis among patients with chronic kidney disease (CKD). Professor Michel Jadoul, who is jointly leading this initiative with Professor... View Article
Learn more
LEARN MORE ABOUT OUR INITIATIVES
To learn more about our initiatives contact us